 |
인쇄하기
취소
|
M&A between Sanofi-Synthelabo and Keunwha went failure.
The business M&A between Sanofi-Synthelabo and Keunwha has gone failure according to their official announcement on Sept. 30.
Earlier on Sept. 3 the National Tax Service interpreted that the agreement for the transfer of Keunwha's pharmaceutical business parts be hardly regarded as a packaged business transfer. After then, Sanofi-Synthelabo tried to negotiate further with their counter partn...
Earlier on Sept. 3 the National Tax Service interpreted that the agreement for the transfer of Keunwha's pharmaceutical business parts be hardly regarded as a packaged business transfer. After then, Sanofi-Synthelabo tried to negotiate further with their counter partn...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.